BioCentury
ARTICLE | Clinical News

Iniparib: Phase II data

August 6, 2012 7:00 AM UTC

Sanofi reported in its 2Q12 earnings that an open-label, European Phase II trial in 141 patients with stage II/IIIa TNBC showed that iniparib plus paclitaxel as neoadjuvant therapy "did not show any a...